BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33924989)

  • 1. Cervical Human Papillomavirus Infection (HPV) and High Oncogenic Risk Genotypes among Women Living with HIV in Asia: A Meta-Analysis.
    Verrier F; Le Coeur S; Delory T
    J Clin Med; 2021 Apr; 10(9):. PubMed ID: 33924989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confronting the human papillomavirus-HIV intersection: Cervical cytology implications for Kenyan women living with HIV.
    Kangethe JM; Gichuhi S; Odari E; Pintye J; Mutai K; Abdullahi L; Maiyo A; Mureithi MW
    South Afr J HIV Med; 2023; 24(1):1508. PubMed ID: 37928501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly active antiretroviral therapy (HAART) and outcome of cervical lesions and high-risk HPV in women living with HIV (WLHIV): A systematic review and meta-analysis.
    Gupta R; Mariano LC; Singh S; Gupta S
    Eur J Obstet Gynecol Reprod Biol; 2022 Nov; 278():153-158. PubMed ID: 36194939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk human papillomavirus infection among women living with HIV in Latin America and the Caribbean: A systematic review and meta-analysis.
    Caicedo-Martínez M; Fernández-Deaza G; Ordóñez-Reyes C; Olejua P; Nuche-Berenguer B; Mello MB; Murillo R
    Int J STD AIDS; 2021 Dec; 32(14):1278-1289. PubMed ID: 34488503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk human papillomavirus genotype distribution among women living with HIV; implication for cervical cancer prevention in a resource limited setting.
    Akakpo PK; Ken-Amoah S; Enyan NIE; Agyare E; Salia E; Baidoo I; Derkyi-Kwarteng L; Asare M; Adjei G; Addo SA; Obiri-Yeboah D
    Infect Agent Cancer; 2023 May; 18(1):33. PubMed ID: 37237313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of human papillomavirus infection in Brazilian women living with HIV: a systematic review and meta-analysis.
    da Silva BEB; de Lemos LMD; de Aragão Batista MV; Lima CA; Martins-Filho PR; Santos VS
    Expert Rev Anti Infect Ther; 2022 Apr; 20(4):611-620. PubMed ID: 34612128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Human Papillomavirus (HPV) genotypes with high-grade cervical neoplasia (CIN2+) in a cohort of women living with HIV in Burkina Faso and South Africa.
    Kelly HA; Ngou J; Chikandiwa A; Sawadogo B; Gilham C; Omar T; Lompo O; Doutre S; Meda N; Weiss HA; Delany-Moretlwe S; Segondy M; Mayaud P;
    PLoS One; 2017; 12(3):e0174117. PubMed ID: 28333966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of HPV Genotypes among HIV Positive Women in Kenya: A Systematic Review and Meta-Analysis.
    Menon S; Wusiman A; Boily MC; Kariisa M; Mabeya H; Luchters S; Forland F; Rossi R; Callens S; Vanden Broeck D
    PLoS One; 2016; 11(10):e0163965. PubMed ID: 27764092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
    Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
    PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of human papillomavirus by geographical regions, sexual orientation and HIV status in China: a systematic review and meta-analysis.
    Ma X; Wang Q; Ong JJ; Fairley CK; Su S; Peng P; Jing J; Wang L; Soe NN; Cheng F; Zhang L
    Sex Transm Infect; 2018 Sep; 94(6):434-442. PubMed ID: 29794242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
    Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
    Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of cervical, oral, and anal human papillomavirus infection in women living with HIV in Denmark - The SHADE cohort study.
    Thorsteinsson K; Storgaard M; Katzenstein TL; Ladelund S; Rönsholt FF; Johansen IS; Pedersen G; Gaardsting A; Nielsen LN; Bonde J; Lebech AM
    J Clin Virol; 2018 Aug; 105():64-71. PubMed ID: 29906660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology.
    Videla S; Darwich L; Cañadas MP; Paredes R; Tarrats A; Castella E; Llatjos M; Bofill M; Clotet B; Sirera G;
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):168-75. PubMed ID: 19131892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Papillomavirus Serology Among Women Living With HIV: Type-Specific Seroprevalence, Seroconversion, and Risk of Cervical Reinfection.
    Kelly H; Faust H; Chikandiwa A; Ngou J; Weiss HA; Segondy M; Dillner J; Delany-Moretlwe S; Mayaud P
    J Infect Dis; 2018 Aug; 218(6):927-936. PubMed ID: 29850832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of cervical high-risk human papillomavirus infection mostly covered by Gardasil-9 prophylactic vaccine in adult women living in N'Djamena, Chad.
    Mboumba Bouassa RS; Nodjikouambaye ZA; Sadjoli D; Adawaye C; Péré H; Veyer D; Matta M; Robin L; Tonen-Wolyec S; Moussa AM; Koyalta D; Belec L
    PLoS One; 2019; 14(6):e0217486. PubMed ID: 31158254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variability of High-Risk Human Papillomavirus and Associated Factors among Women in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.
    Tchouaket MCT; Ka'e AC; Semengue ENJ; Sosso SM; Simo RK; Yagai B; Nka AD; Chenwi CA; Abba A; Fainguem N; Perno CF; Colizzi V; Fokam J
    Pathogens; 2023 Aug; 12(8):. PubMed ID: 37623992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of human papillomavirus infection in HIV-infected women living in French Antilles and French Guiana.
    Abel S; Najioullah F; Voluménie JL; Accrombessi L; Carles G; Catherine D; Chiappetta D; Clavel C; Codjo-Sodokine A; El Guedj M; Jean-Marie J; Molinié V; Pierre-François S; Stegmann-Planchard S; Vantilcke V; Vaz T; Nacher M; Cabié A; Césaire R;
    PLoS One; 2019; 14(9):e0221334. PubMed ID: 31483832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of and Risk Factors for Anal Oncogenic Human Papillomavirus Infection Among HIV-Infected Women in France in the Combination Antiretroviral Therapy Era.
    Heard I; Poizot-Martin I; Potard V; Etienney I; Crenn-Hebert C; Moore C; Touraine P; Cubie H; Costagliola D;
    J Infect Dis; 2016 May; 213(9):1455-61. PubMed ID: 26690345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of type-specific oncogenic human papillomavirus infection assessed by HPV E6/E7 mRNA among women with high-grade cervical lesions.
    Wang HY; Park S; Lee D; Kim S; Kim G; Park KH; Lee H
    Int J Infect Dis; 2015 Aug; 37():135-42. PubMed ID: 26141414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.